Latest Manufacturing News

Imagion Biosystems has completed manufacturing its MagSense® HER2 imaging agent, progressing toward a Phase 2 clinical trial with strong collaborations and a recent AU$3.5 million capital raise.

Mesoblast Limited reports a robust 66% increase in Ryoncil revenues for Q2 2025, driven by strong market adoption and new Medicare reimbursement codes.

St George Mining secures government support to establish a cutting-edge pilot plant and research centre at its Araxá Project, aiming to refine rare earth and niobium processing in Brazil. This initiative builds on historic metallurgical success and positions the company at the forefront of critical metals supply chain development.

Fortuna Metals has identified significant historical titanium mineralisation across its Mkanda and Kampini projects in Malawi, with Phase 1 drilling complete and assay results expected soon. Positioned near Sovereign Metals’ world-class Kasiya deposit, Fortuna’s exploration could unlock a major rutile discovery.

DroneShield is investing $13 million over three years to open a new counter-drone research facility in Adelaide, marking a key step in its global growth and technology development.

Epsilon Healthcare Limited reported a $3.25 million loss for 2024, reflecting the financial strain of voluntary administration and efforts to rebuild operations and client confidence.

Nanoveu’s subsidiary EMASS has initiated live flight tests using the Crazyflie nano-drone to validate simulation results showing over 50% endurance gains from its ECS-DoT AI chip. These trials aim to confirm real-world energy savings and autonomous navigation capabilities with minimal sensors.

Sheffield Resources has reported a record quarter at its Thunderbird Mineral Sands Mine, with significant increases in ore mined and concentrate production, signaling a strong operational turnaround.

Boab Metals is set to list on the U.S. OTCQB market, aiming to tap into American investor interest and capitalise on rising silver prices. This move complements its ASX listing and highlights its advanced Sorby Hills project.

The U.S. FDA has lifted the clinical hold on Neurizon Therapeutics’ lead drug candidate NUZ-001, enabling its entry into a major ALS platform trial set for Q4 2025. This regulatory milestone accelerates the company’s clinical development and opens doors for broader neurodegenerative applications.

First Graphene has launched its PureGRAPH-enhanced waterproofing additive in South Africa, marking a significant step into the regional cement and concrete sector with promising trial results and initial commercial orders.

Weebit Nano has successfully taped out embedded ReRAM test chips at onsemi’s 65nm BCD fab, marking a critical step toward commercialising its low-power memory technology in automotive and AI markets.